Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Michael U. Callaghan, MD
Healthcare Provider Director
Sickle Cell Center
Children's Hospital of Michigan
3901 Beaubien St.
Detroit, Michigan, United States
Michael U. Callaghan, MD, is Associate Professor of Pediatric Hematology/Oncology at Wayne State University School of Medicine and Director of the Sickle Cell Center at the Children’s Hospital of Michigan. He received his medical degree from Wayne State University, and completed his pediatric residency and pediatric hematology/oncology fellowship at Children’s Hospital of Michigan.
Dr. Callaghan cares for more than 100 children and adults with hemophilia and has served as Medical Director of Camp Bold Eagle hemophilia camp. He participates in basic, translational, and clinical research. Dr. Callaghan has authored or coauthored over 50 peer-reviewed articles that have been published in journals such as Haemophilia, Blood, Nature Genetics, and The New England Journal of Medicine. He is the previous recipient of the John Penner Award from the Hemophilia Foundation of Michigan and has been featured in Top Doctors in America.
Clinical interests:
Bleeding Disorders
Hemophilia and its Complications
von Willebrand Disease ITP and other immune cytopenias
Polycythemia
Congenital bone marrow failure
Sickle cell disease
Hemoglobinopathies
Research interests:
Clotting factor inhibitors
New Coagulation
Unfolded Protein Response
Translational hematology and early clinical trials with emphasis on drug discovery
Sickle cell disease
Hemoglobinopathies
+myBinderRelated Content
-
Isaac Odame, MB ChB, MRCP, FRCPath, FRCPCH, FRCPCDr. Isaac Odame is a staff physician and...
-
Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: The role ...Despite its rarity in the United States,...
-
Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of CareImportance: Sickle cell disease (SCD) i...
-
Allison A. King, MD, MPH, PhDDr. King is a pediatric hematologist and...
-
Children’s National Health SystemSickle cell disease affects many familie...
-
Citizens for Quality Sickle Cell CareThe New England Sickle Cell Institute at...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
